Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $81.06 -0.17%
EPS Growth %: -46.4%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -46.4%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.82 million versus the consensus estimate of $1.06 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
- Yiren Digital Ltd. (YRD) Reports Q1 Loss of RMB5.64
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
